You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (153)

Journals (0)

1-10 of 153 results for FDA policy

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: FDA Policy on Unapproved Drug Products: Past,Present,and Future

Retricted access

Research article

First published 2005-7

FDA Policy on Unapproved Drug Products: Past,Present,and Future

Renu Chhabra, Mary E Kremzner, Brenda J Kiliany

Annals of Pharmacotherapy

Select article: Assessment of the FDA Backgrounder on Platinum in Silicone Breast Implants: Implications for Public Health Policy

Retricted access

Research article

First published 2008-1

Assessment of the FDA Backgrounder on Platinum in Silicone Breast Implants: Implications for Public Health Policy

S. V. M. Maharaj

International Journal of Social Determinants of Health and Health Services

Select article: The AIDS Consumer Movement and the FDA: A Potential Paradigm Shift in Health Care Policy

Retricted access

Research article

First published 1989

The AIDS Consumer Movement and the FDA: A Potential Paradigm Shift in Health Care Policy

Stephen J. Gould

Journal of Public Policy & Marketing

Select article: Needs and New Policies for Medicines for Children: The FDA,United States Incentives,and International Doings

Retricted access

Other

First published 2000-1

Needs and New Policies for Medicines for Children: The FDA,United States Incentives,and International Doings

Paula Botstein

Therapeutic Innovation & Regulatory Science

Select article: Current FDA Policies on Drug Promotion

Retricted access

Other

First published 1989-10

Current FDA Policies on Drug Promotion

Louis A. Morris, David Banks

Therapeutic Innovation & Regulatory Science

Select article: Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies

Free access

Research article

First published 2024-2

Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies

Kevin S. McDorman, Bindu M. Bennet, Karyn Colman [...]

Toxicologic Pathology

Select article: FDA Policy on Comparative Prescription Drug Advertising

Retricted access

Research article

First published 1983-4

FDA Policy on Comparative Prescription Drug Advertising

Lloyd G. Millstein

Therapeutic Innovation & Regulatory Science

Select article: In Silico Toxicology: Integration into Current FDA Policies and Procedures

Retricted access

Research article

First published 2006-08

In Silico Toxicology: Integration into Current FDA Policies and Procedures

Andrew S. Meyers

Biotechnology Law Report

Select article: From policy to practice: Evaluating the global implications of the FDA’s PDURS framework

Open access

Review article

First published 2026

From policy to practice: Evaluating the global implications of the FDA’s PDURS framework

Yingbo Zhang, Li Shen, Shan He [...]

DIGITAL HEALTH

Select article: What’s the Hold Up? The FDA’s Delayed Implementation of Menu-Labeling Policy

Retricted access

Research article

First published 2022-7

What’s the Hold Up? The FDA’s Delayed Implementation of Menu-Labeling Policy

Wenhui Feng, Ashley M. Fox

Administration & Society

1
2
3
•••
16
10 / page

Article type

Publication date

Subjects

Access